Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometryFan Zhang, Soumya Raychaudhuri, Nida Meednu et al.|Nature Immunology|2019Cited by 1.4k
Notch signalling drives synovial fibroblast identity and arthritis pathologyKevin Wei, Fumitaka Mizoguchi, Ilya Korsunsky et al.|Nature|2020Cited by 540
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trialFrances Humby, Raquel Celis, Patrick Durez et al.|The Lancet|2021Cited by 315
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trialFelice Rivellese, Raquel Celis, Anna E. A. Surace et al.|Nature Medicine|2022Cited by 277
Defining Inflammatory Cell States in Rheumatoid Arthritis Joint Synovial Tissues by Integrating Single-cell Transcriptomics and Mass CytometryFan Zhang, Soumya Raychaudhuri, Kevin Wei et al.|bioRxiv (Cold Spring Harbor Laboratory)|2018Cited by 144